Podcasts
CLEAR
X
Heritage
Deep Experience
Worldwide Biologics Leader
Therapeutic Area Heritage
Expertise
Highly Specialized Knowledge
Discovery
Manufacturing
Clinical Testing
Quality Assurance
Therapeutic Area Expertise
Commitment
Biologics Development
Significant Investments
Impacts of Biosimilars
Therapeutic Area Commitment
2022 Biosimilar Trends Report
Support
Solution-Oriented Services
Value
Our Products
FDA-Approved Products
Our Pipeline
Clinical Trials
Media
Media Releases
Amgen in the News
Amgen US Biosimilars Policy Positions
Biosimilars Education
About Biosimilars
Prescribing Biosimilars
Biosimilars Development and Regulatory Pathways
Biosimilars Resources
Biosimilars Glossary
Menu Description
Biosimilars Education
>
Biosimilars Resources
>
Podcasts
>
Podcasts
Biosimilars Education
About Biosimilars
Potential Benefits and Value of Biosimilars
Biologics vs. Generics
Biosimilars vs. Reference Biologics
Biosimilars vs. Noncomparables
Biosimilars Interchangeability
Biosimilars Naming and Labeling
Prescribing Biosimilars
Cost Savings & Value-Based Care
Biosimilars Safety & Efficacy
Discussing Biosimilars With Patients
Biosimilars Development and Regulatory Pathways
Complexities of Biosimilar Development
Clinical Trials
Regulatory Approval Pathways
Reliable Supply Chain
Extrapolation
Biosimilars Resources
Podcasts
Biosimilars Glossary
